Long-term therapy with addition of pioglitazone to metformin compared with the addition of gliclazide to metformin in patients with type 2 diabetes: a randomized, comparative study
Long-term therapy with addition of pioglitazone to metformin compared with the addition of gliclazide to metformin in patients with type 2 diabetes: a randomized, comparative study
复制标题
DOI：
10.1002/dmrr.478
复制
发表时间：
2005-03-01
影响因子：
8
通讯作者：
Schernthaner, G
中科院分区：
文献类型：
--
作者：
Matthews, DR;Charbonnel, BH;Schernthaner, G
背景这项为期52周的随机双盲研究比较了二甲双胍加吡格列酮与二甲双胍加格列齐特联合治疗2型糖尿病的疗效和安全性。
Background This 52-week, randomized, double-blind study compared the efficacy and safety of metformin plus pioglitazone with the established combination of metformin plus gliclazide in type 2 diabetes mellitus.Methods Patients with poorly controlled type 2 diabetes (HbA(1c) >= 7.5% to